Alpha Tau Medical

Yahoo Finance • 9 days ago

Alpha Tau Eyes Year-End Japanese Clearance For Alpha DaRT Treatment In Recurrent Head & Neck Cancer

(RTTNews) - Alpha Tau Medical Ltd. (DRTS), a clinical-stage oncology company pioneering Alpha DaRT for solid tumors, has several key milestones approaching in the next few months. The company's lead therapeutic platform, Alpha DaRT, is be... Full story

Yahoo Finance • 9 days ago

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update

- Alpha DaRT pancreatic cancer patient treatments underway in U.S. multi-center pilot study - - Newly received radioactive material license for New Hampshire facility positions the Company for continued advancement towards commercial read... Full story

Yahoo Finance • last month

Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness

- Receipt of critical license marks significant milestone for first commercial-scale manufacturing facility for Alpha DaRT®, the innovative alpha-radiation cancer therapy designed for potent and conformal tumor irradiation - -License pave... Full story

Yahoo Finance • 3 months ago

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

– First patient treatment marks successful initiation of multi-center pilot study in Alpha DaRT U.S. pancreatic cancer program – – Study explores Alpha DaRT® combined with chemotherapy in patients with newly diagnosed unresectable locally... Full story

Yahoo Finance • 3 months ago

Alpha Tau to Participate in Five September Investor Conferences

JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy wi... Full story

Yahoo Finance • 5 months ago

Alpha Tau files to sell 3.46M ordinary shares by selling shareholders

* Alpha Tau (NASDAQ:DRTS [https://seekingalpha.com/symbol/DRTS]) filed a prospectus to sale 3.46 million ordinary shares. * The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder. * This... Full story

Yahoo Finance • 2 years ago

Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now

MIAMI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023. The Emerging Growth Conference identif... Full story

Yahoo Finance • 2 years ago

Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now

MIAMI, Oct. 04, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of Day 2 of the 63rd Emerging Growth Conference on October 5th, 2023. The Emerging Growth Conference identif... Full story

Yahoo Finance • 2 years ago

Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now

MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 63rd Emerging Growth Conference on October 4th and 5th, 2023. The Emerging Growth Conference identifi... Full story

Yahoo Finance • 2 years ago

Presenting on the Emerging Growth Conference on September 6 and 7 Register Now

MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 62nd Emerging Growth Conference on September 6 & 7, 2023. The Emerging Growth Conference identifies... Full story

Yahoo Finance • 2 years ago

Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April – – 89% CR, two-year local recurrence-free survival of 77%, and no treatment-related grade 2 or higher late-onset... Full story

Yahoo Finance • 2 years ago

Alpha Tau Medical to Participate in September Investor Conferences

JERUSALEM, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that management will p... Full story

Yahoo Finance • 3 years ago

Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day

JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that Raphi Levy, Chief... Full story

Yahoo Finance • 3 years ago

Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit

JERUSALEM, March 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that Raphi Levy, Chie... Full story